Gus Bassani, PharmD, PCCA Chief Scientific Officer, joins co-hosts Mike De Lisio and Sebastian Denison, RPh, to discuss PCCA’s high-purity, pharmaceutical-grade cannabidiol powder. Gus addresses the regulatory changes that led to this cannabidiol powder being available for compounding and answers some common questions about using this ingredient in personalized medicine.